Since 1998, drug companies have spent $758 million on lobbying
-- more than any other industry. That is over half a billion dollars
that have a dramatic influence on how drugs are viewed politically.
Since the government ultimately determines which products drug
companies can market and how they're labeled, their lobbying is
really having a serious impact on you. So, with the drug industry
facing the possibility of increased regulation -- due to mounting
concerns about the safety of the nation's drug supply -- many drug
companies are doing whatever it takes to wine and dine members of
Congress to lean in their favor.
For example, the drug companies' corporate planes have been made
available for dozens of trips taken by powerful lawmakers. The absolute
clincher, however, is the amount of money drug companies are willing
to spend in order to protect themselves and their drugs for meeting
their doom.
Big Spenders
Drug companies and their officials contributed at least $17 million
to federal candidates in last year's elections, including:
- Nearly $1 million to President Bush.
- More than $500,000 to his opponent, John Kerry.
- At least 18 members of Congress received more than $100,000
apiece.
And if that doesn't seem like enough schmoozing, consider this
fact again: Drug companies have spent more than $750 million over
the past seven years on lobbying alone. According to government
records analyzed by the Center for Public Integrity, that's more
than any other industry!
Lobbyists' Political Success
The drug industry employs almost 1,274 lobbyists, including 40
former members of Congress. Over the years those lobbyists have
been extremely successful, proving they know politics just as well
as they know chemistry. Specifically, they've:
-
Won coverage for prescription drugs under Medicare in 2003
while preventing the government from negotiating prices downward.
-
So far kept out imports of cheaper medicines from Canada and
other countries.
-
Protected a system that uses company fees to speed the drug-approval
process.
Unfortunately, this information serves as a sad reminder of just
how deeply the mega-pharmaceutical industry
influenceswhat is seen and heard in the media.
USA
Today April 26, 2005
|